Why Is Oncology Demand Fueling the PARP Inhibitors Market Growth?
PARP Inhibitors Market is experiencing strong growth due to rising global oncology burden and increasing demand for targeted cancer treatments. Cancer remains one of the leading causes of mortality worldwide, driving significant investment in advanced therapeutic solutions. PARP inhibitors have emerged as an effective treatment option for genetically linked cancers, particularly in patients...